Trevor M. Jones

Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW (born on 19 August 1942) is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.

He was main board director for Research & Development at The Wellcome Foundation Ltd (Wellcome plc). During his tenure, the organisation was responsible for the development of a number of significant products.

Jones assisted the Government to attract inward investment into the UK, particularly from the Japanese pharmaceutical companies through the "Prescribe UK" initiative (with Virginia Bottomley and David Sainsbury). He also led negotiations with the UK Government on the Pharmaceutical Price Regulation Scheme (PPRS) when he was head of the ABPI. Until recently he advised the Wales Government on the future of the NHS as a member of The Bevan Commission. He is also chairman of the Drug Discovery company, e-Therapeutics plc. Provided by Wikipedia